Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles
about
HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applicationsCardioprotective functions of HDLsSphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protectionSelective evaluation of high density lipoprotein from mouse small intestine by an in situ perfusion technique.The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus.Effects of cholesterol on thermal stability of discoidal high density lipoproteins.Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetesProteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairmentOxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patientsHDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate.Blood sphingolipidomics in healthy humans: impact of sample collection methodology.Improving heart function by modulating myocardiocyte autophagy: a possible novel mechanism for cardiovascular protection of high-density lipoproteinClass II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis.Human HDL containing a novel apoC-I isoform induces smooth muscle cell apoptosis.High density lipoprotein: it's not just about lipid transport anymoreAldosterone production in human adrenocortical cells is stimulated by high-density lipoprotein 2 (HDL2) through increased expression of aldosterone synthase (CYP11B2)Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory propertiesStatin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia.Sphingosine 1-phosphate distribution in human plasma: associations with lipid profiles.The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generationSphingomyelin in high-density lipoproteins: structural role and biological function.High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway.HDL and endothelial protection.Concentration of Smaller High-Density Lipoprotein Particle (HDL-P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA)Why targeting HDL should work as a therapeutic tool, but has not.Unraveling the complexities of the HDL lipidomeDifferential stability of high-density lipoprotein subclasses: effects of particle size and protein composition.Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins.Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I.High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular diseaseProtection from Cardiovascular Disease Due to Increased High-Density Lipoprotein Cholesterol in African Black Populations: Myth or Reality?High-density lipoprotein metabolism and the human embryo.Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations.The emerging role of plasma lipidomics in cardiovascular drug discovery.Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.Molecular biology of atherosclerosis.High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.
P2860
Q26779667-F0EC8575-3C5C-4084-9EBF-540C46AD4B49Q27000421-083073A2-D6F9-4243-A6C4-3525DD9ACBBEQ28235893-8BA701A5-9483-4C66-B2D6-0EE6A588E193Q30576734-CFA29601-9B37-46ED-AE6A-2DAD7693687AQ30578060-90E39F33-5F0C-4873-8E45-5ED5BBBE368FQ33577845-E2BEDD3A-A6B5-4155-A2A9-A4BA9C5EFD65Q33582205-2EFAE84A-0BC4-4A23-8872-AF9C4953EC4AQ33752486-8F36753C-35C6-4C52-BA75-05AD8C357355Q33878870-029C4AF0-FCD6-46CA-BB1A-96044914CB3FQ33888423-A09B5836-13DF-40BB-8C27-B862BEC2C3DBQ34053101-1EFBB8AE-2D8C-4991-A2CC-5A84D6277BE9Q34116310-162B7DB1-B091-4467-B312-9E343D198E6CQ34439003-F8D3CB0F-E313-4FB2-9350-60A6D5E0D595Q34548346-306E8A86-AB99-41AA-B193-5C1FD609295EQ34564734-B9B03529-430E-4E1A-A97E-2EB01E073F39Q34565254-D285D758-F095-4C09-B9AC-7DDBFDA866C4Q34578466-85F7009E-A9ED-46EA-B5E6-5B51F387EA83Q34814166-3AA3B6D5-CBD5-4740-AA62-01B3F6A3A6D8Q35994365-36CDFE37-00A8-4489-93C3-8327CAAD8C99Q36307308-A5F20ADE-14C6-49AF-9A95-8AC36597E3A7Q36415245-663B5D55-DD24-408E-A045-E10FB6DBE860Q36701853-32AEEBD3-65A4-4D7B-8665-848593251CCDQ36820504-9362D6F6-10E9-49FE-AB53-749BF5CC27EDQ36895483-2A3D88DE-78DA-46EC-B9E3-A2AB9ACEBF4CQ36929420-DFF475D8-77B0-49F4-808F-B42ED3A8F2A1Q36956691-F908AC75-D31E-423E-AFFA-7E8C6E9AE29AQ37170464-2CF767BE-3143-42B6-A45A-E60DB32860C1Q37222656-96AF61D8-C82B-4F1E-A906-9DAA57B8AC60Q37252779-E714B6BC-9C4A-409F-A179-7ED48CB83989Q37278677-CDBCDB28-AAA6-4E11-BDB0-5BB510984735Q37296317-578E3469-0E36-450A-99AD-7B2697BF288CQ37305341-0723321A-58CB-407C-B5CF-1737B592E3DCQ37354102-40C11865-214A-4E91-83CD-4192DC3C7DEFQ37584875-30B83EC0-4717-4884-B1BF-EE6BD0A8A14FQ37871354-EC9A445C-6049-4FF5-A122-65841DC3E0E8Q37900093-6DC6FDDD-260F-4E25-B1AD-5FE458CED40DQ37999089-6488A9AF-E5CF-4874-A80A-467EA2365EBAQ38124049-E37C39BC-11FC-4110-AC9A-71F0A1556542Q38125279-9BB66610-2B36-4430-8190-DA0D9A9995CBQ38220761-8F050B72-0EEA-41CE-AFB1-922F79F668D9
P2860
Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles
description
article
@en
im Juni 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2007
@uk
name
Preferential Sphingosine-1-Pho ...... of Small Dense HDL3 Particles
@en
Preferential Sphingosine-1-Pho ...... of Small Dense HDL3 Particles
@nl
type
label
Preferential Sphingosine-1-Pho ...... of Small Dense HDL3 Particles
@en
Preferential Sphingosine-1-Pho ...... of Small Dense HDL3 Particles
@nl
prefLabel
Preferential Sphingosine-1-Pho ...... of Small Dense HDL3 Particles
@en
Preferential Sphingosine-1-Pho ...... of Small Dense HDL3 Particles
@nl
P2093
P1476
Preferential sphingosine-1-pho ...... c and antioxidative activities
@en
P2093
Amal Zerrad
Anatol Kontush
Anne Négre-Salvayre
Juliana A de Souza
M John Chapman
Martine Couturier
Patrice Therond
P304
P356
10.1161/ATVBAHA.107.145672
P407
P577
2007-06-14T00:00:00Z